Currently, Society enjoys a well-deserved international reputation and unifies researchers representing related areas from all over the world. Annual Society meetings are among the most significant in biomedical sciences; Journal of Controlled Release is among the highest rated journals in the field of experimental pharmacology. However, we must be prepared to meet the challenges of the future and continue to work hard to maintain our current level of performance. An important role in the future development of the CRS belongs to Local Chapters, which over the years, have developed into an established, recognized, and extremely valuable institute within the Society. The UKICRS traditionally is one of the leaders and a role model among many Chapters and as incoming President of the CRS, I sincerely wish it the further success in recruiting new members of the CRS/UKICRS from various related academic disciplines and industries, increasing Society visibility by informing junior professionals and general public about the achievements and challenges in controlled delivery of biologically active substances, promoting closer association of the Society with pharmaceutical education, and enhancing Society cooperation with pharmaceutical technology and clinical medicine.Professor Vladimir Torchilin
|
In the new millennium, pharmaceutical biotechnology and nanotechnology/nanomedicine are becoming increasingly important. One of the key areas in pharmaceutical biotechnology and related aspects of nanotechnology is the development of new and efficient systems for delivery of biologically active compounds. It is of primary importance for clinical and diagnostic medicine, veterinary medicine, the pharmaceutical industry, cosmetics, environment protection and the food industry. In other words, in all areas developed to improve the quality of living. Within this context, the role of the Controlled Release Society, which is the only international society covering all possible and imaginable areas of new formulations and new delivery systems of biologically active compounds, is impossible to overestimate.
